No headlines found.
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
Globe Newswire (Wed, 29-Jul 8:00 AM ET)
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
Globe Newswire (Mon, 13-Jul 10:15 PM ET)
Tevogen Announces Formation of a Healthcare Services Initiative
Globe Newswire (Tue, 9-Jun 3:30 PM ET)
Globe Newswire (Thu, 28-May 12:30 PM ET)
Globe Newswire (Thu, 21-May 12:15 PM ET)
Letter to Shareholders from CEO Dr. Ryan Saadi
Globe Newswire (Mon, 18-May 12:15 PM ET)
Globe Newswire (Tue, 12-May 11:45 AM ET)
Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.
Tevogen trades on the NASDAQ stock market under the symbol TVGN.
As of August 11, 2026, TVGN stock price climbed to $6.65 with 6,824 million shares trading.
TVGN has a beta of 3.02, meaning it tends to be more sensitive to market movements. TVGN has a correlation of 0.10 to the broad based SPY ETF.
TVGN has a market cap of $28.06 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that TVGN belongs to (by Net Assets): VTI, VXF.
TVGN has underperformed the market in the last year with a return of -86.4%, while the SPY ETF gained +22.4%. In the last 3 month period, TVGN fell short of the market, returning -5.0%, while SPY returned +4.5%. However, in the most recent 2 weeks TVGN has outperformed the stock market by returning +19.0%, while SPY returned +4.0%.
TVGN support price is $5.67 and resistance is $7.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TVGN shares will trade within this expected range on the day.